Yinan Liu

1.4k total citations
36 papers, 985 citations indexed

About

Yinan Liu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yinan Liu has authored 36 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 8 papers in Surgery. Recurrent topics in Yinan Liu's work include Lung Cancer Treatments and Mutations (16 papers), Gastric Cancer Management and Outcomes (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Yinan Liu is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Gastric Cancer Management and Outcomes (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Yinan Liu collaborates with scholars based in China, Taiwan and United States. Yinan Liu's co-authors include Jin‐Yuan Shih, Shang‐Gin Wu, James Chih‐Hsin Yang, Meng‐Feng Tsai, Yujie Yan, Chong‐Jen Yu, Baodong Yao, Hong Fang, Pan‐Chyr Yang and Wanghong Xu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Aquaculture.

In The Last Decade

Yinan Liu

34 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinan Liu China 15 484 394 241 127 124 36 985
Yuko Yamamura United States 17 203 0.4× 345 0.9× 221 0.9× 109 0.9× 219 1.8× 31 1.1k
Kirk Snyder United States 15 106 0.2× 158 0.4× 275 1.1× 123 1.0× 159 1.3× 19 839
A Gentile Italy 10 161 0.3× 239 0.6× 132 0.5× 191 1.5× 93 0.8× 18 811
Elizabeth M. Masko United States 14 324 0.7× 280 0.7× 244 1.0× 86 0.7× 386 3.1× 17 979
Heba F. Pasha Egypt 18 79 0.2× 135 0.3× 288 1.2× 106 0.8× 159 1.3× 42 919
Sagar Sardesai United States 13 92 0.2× 174 0.4× 175 0.7× 50 0.4× 90 0.7× 47 603
Monica Cipollini Italy 14 205 0.4× 113 0.3× 291 1.2× 35 0.3× 166 1.3× 28 709
Lara E. Sucheston‐Campbell United States 16 103 0.2× 237 0.6× 281 1.2× 59 0.5× 186 1.5× 45 789
Kainan Wu China 13 74 0.2× 262 0.7× 228 0.9× 99 0.8× 233 1.9× 61 905
Tiankang Guo China 19 257 0.5× 264 0.7× 218 0.9× 26 0.2× 77 0.6× 48 815

Countries citing papers authored by Yinan Liu

Since Specialization
Citations

This map shows the geographic impact of Yinan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinan Liu more than expected).

Fields of papers citing papers by Yinan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinan Liu. The network helps show where Yinan Liu may publish in the future.

Co-authorship network of co-authors of Yinan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yinan Liu. A scholar is included among the top collaborators of Yinan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinan Liu. Yinan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiali, et al.. (2024). Network Pharmacology-Based Strategy to Explore the Effect and Mechanism of Zhizhu Granule Improving Glucose-Lipid Metabolism in Rats with Metabolic Syndrome. Diabetes Metabolic Syndrome and Obesity. Volume 17. 3833–3846. 1 indexed citations
2.
Liu, Yinan, Chaoyue Zhang, Jinning Ye, et al.. (2024). Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis. The Journal of Pathology Clinical Research. 10(3). e12378–e12378. 4 indexed citations
3.
Li, Jiong, Maohua Miao, Yao Chen, et al.. (2024). Associations of gestational exposure to organophosphate esters with thyroid hormones in cord plasma and the safety threshold of exposure in pregnant women. Environmental Research. 267. 120639–120639. 2 indexed citations
6.
Wu, Shang‐Gin, Tzu‐Hua Chang, Meng‐Feng Tsai, et al.. (2023). miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44. Molecular Therapy — Nucleic Acids. 35(1). 102091–102091. 12 indexed citations
8.
Gow, Chien‐Hung, Min‐Shu Hsieh, Yilin Chen, et al.. (2023). Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study. Frontiers in Oncology. 13. 1113696–1113696. 4 indexed citations
9.
Liu, Yinan, et al.. (2022). The Benefits of Medicaid Home and Community- Based Services on Health. SSRN Electronic Journal.
10.
Liu, Yinan, Yiqing Liu, Jing Yang, et al.. (2021). Chinese herbal medicine for hypertension complicated with hyperlipidemia. Medicine. 100(6). e24345–e24345. 2 indexed citations
11.
Lyu, Chao, Rui Wang, Shaolei Li, et al.. (2021). Different exposure duration of adjuvant icotinib in stage II-IIIA non-small cell lung cancer patients with positive EGFR mutation (ICOMPARE study): A randomized, open-label phase 2 study.. Journal of Clinical Oncology. 39(15_suppl). 8521–8521. 8 indexed citations
12.
Fan, Yanyan, et al.. (2019). Intrauterine cystic adenomyosis: Report of two cases. World Journal of Clinical Cases. 7(5). 676–683. 9 indexed citations
13.
Fan, Yanyan, et al.. (2017). Serum level concentrations of pro-inflammatory cytokines in patients with adenomyosis. Biomedical Research-tokyo. 28(4). 1809–1813. 4 indexed citations
14.
Fang, Hong, et al.. (2016). Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China. Scientific Reports. 6(1). 39633–39633. 37 indexed citations
15.
Gow, Chien‐Hung, Wei‐Yu Liao, Yinan Liu, & Jin‐Yuan Shih. (2015). Discordant HER2 Exon 20 Mutation Status Determines a Differential Sensitivity to Afatinib. Journal of Thoracic Oncology. 10(7). e58–e60. 14 indexed citations
16.
Yao, Baodong, Hong Fang, Wanghong Xu, et al.. (2014). Dietary fiber intake and risk of type 2 diabetes: a dose–response analysis of prospective studies. European Journal of Epidemiology. 29(2). 79–88. 200 indexed citations
17.
Yao, Baodong, Yujie Yan, Hong Fang, et al.. (2014). Intake of fruit and vegetables and risk of bladder cancer: a dose–response meta-analysis of observational studies. Cancer Causes & Control. 25(12). 1645–1658. 39 indexed citations
18.
Chen, Yen‐Fu, Min‐Shu Hsieh, Shang‐Gin Wu, et al.. (2014). Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations. Journal of Thoracic Oncology. 9(8). 1171–1179. 66 indexed citations
19.
Liu, Yinan, et al.. (2014). Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma. World Journal of Surgical Oncology. 12(1). 43–43. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026